Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Human Polyclonal DPYSL2 Primary Antibody for IHC - ABIN966010
Goshima, Nakamura, Strittmatter, Strittmatter: Collapsin-induced growth cone collapse mediated by an intracellular protein related to UNC-33. in Nature 1995
Show all 5 Pubmed References
Human Polyclonal DPYSL2 Primary Antibody for IF (p), IHC (p) - ABIN734468
Zheng, Liu, Li, Tang, Zhang, Tang: Lithium posttreatment confers neuroprotection through glycogen synthase kinase-3β inhibition in intracerebral hemorrhage rats. in Journal of neurosurgery 2016
Human Monoclonal DPYSL2 Primary Antibody for IF, ELISA - ABIN515065
OBrien, Shen, Tachikawa, Lee, Briggs: Quantitative proteome analysis of pluripotent cells by iTRAQ mass tagging reveals post-transcriptional regulation of proteins required for ES cell self-renewal. in Molecular & cellular proteomics : MCP 2010
Human Polyclonal DPYSL2 Primary Antibody for ELISA, WB - ABIN2473109
Kawano, Yoshimura, Tsuboi, Kawabata, Kaneko-Kawano, Shirataki, Takenawa, Kaibuchi: CRMP-2 is involved in kinesin-1-dependent transport of the Sra-1/WAVE1 complex and axon formation. in Molecular and cellular biology 2005
crystal structure of human tetrameric CRMP-2
These data identify a novel oncogenic mechanism where CDK5 (show CDK5 Antibodies) activation induces CRMP2A phosphorylation in the nuclei of tumour cells
polymorphisms of the DPYSL2 gene in humans may be associated with the development of schizophrenia.
Functional variants in DPYSL2 sequence increase risk of schizophrenia and suggest a link to mTOR (show FRAP1 Antibodies) signaling
Changes for CRMP2, TCP1epsilon, TPM2 (show TPM2 Antibodies) and 14-3-3gamma (show YWHAG Antibodies) were confirmed in experimental tumors and in a series of 28 human SI-NETs.
Reduced CRMP2 expression and elevated expression of nuclear phosphorylated CRMP2 may be associated with breast cancer progression.
Levels of total GSK3 (show GSK3b Antibodies) were decreased in the Huntington disease (show HTT Antibodies)-affected frontal cortex and this correlated with decreased phosphorylated CRMP2.
High dihydropyrimidinase-related protein 2 expression is associated with lung cancer.
genetic variants in DPYSL2 may play a role in susceptibility to alcohol dependence.
A specific and reversible intermolecular Cys (show DNAJC5 Antibodies)-504-Cys (show DNAJC5 Antibodies)-504 dithiol-disulfide switch in homotetrameric CRMP2 determines two conformations of the quaternary CRMP2 complex that controls axonal outgrowth and thus neuronal development.
phosphorylation of Dpysl2 and Dpysl3 (show DPYSL3 Antibodies) by Cyclin-dependent kinase 5 (show CDK5 Antibodies) and dual-specificity tyrosine-phosphorylated and regulated kinase 2 is required for correct positioning of CaP motor neurons in the zebrafish spinal cord
These results suggest that the phosphorylation of Dpysl2 and Dpysl3 (show DPYSL3 Antibodies) by Cdk5 (show CDK5 Antibodies) and DYRK2 (show DYRK2 Antibodies) is required for the proper positioning of Rohon-Beard neurons and neural crest cells during neurulation in zebrafish embryos.
From 20 somites through 30 hpf CRMP2 is expressed in the dorsal rostral cluster of the telencephalon, the ventral rostral cluster of the diencephalon, the ventral caudal (show CAD Antibodies) cluster of the mesencephalon, and the hindbrain clusters.
The findings reveal a critical role for CRMP2 in neuronal plasticity, neural function and behavioral modulation in mice.
Results suggested that crmp2 is a target of miR (show MLXIP Antibodies)-181c and that the abnormally low expression of miR (show MLXIP Antibodies)-181c in the hippocampus of SAMP8 mice could lead to an increase of the crmp2 protein level in Alzheimer's disease mice, which might potentially play a role in the pathogenesis of Alzheimer's disease
These results suggest a correlation between CRMP2 phosphorylation and AD pathophysiology, and indicate the effectiveness of pioglitazone treatment at the pre-Abeta (show APP Antibodies) accumulation stage in AD model mice.
We generated CRMP2 gene-deficient (crmp2(-/-) ) mice. The crmp2(-/-) mice showed irregular development of dendritic spines in cortical neurons. The level of CRMP1 (show CRMP1 Antibodies) was increased in crmp2(-/-) , but the level of CRMP2 was not altered in crmp1 (show CRMP1 Antibodies)(-/-).The phenotypic defects had no genetic interaction between crmp1 (show CRMP1 Antibodies) and crmp2.
study implies that dysregulation of CRMP2 may be involved in pathophysiology of neuropsychiatric disorders
we demonstrate that Cdk5 (show CDK5 Antibodies) phosphorylates collapsin response mediator protein 2 (CRMP2) in the dendritic spines of cultured hippocampal neurons and in vivo in the mouse brain. When we eliminated CRMP2 phosphorylation in CRMP2(KI/KI (show AXIN1 Antibodies)) mice, the densities of dendritic spines significantly decreased in hippocampal CA1 (show CA1 Antibodies) pyramidal neurons in the mouse brain.
We propose that CRMP2 could contribute to long-lasting synaptic plasticity.
This study shows that in young adult mice, motor and sensory functions lost by SCI can be recovered with a single genetic mutation to inhibit CRMP2 phosphorylation
Study showed that axon degeneration is an early and dominant feature in dopaminergic neurons treated with 1-methyl-4-phenylpyridiniumion (MPP+), and that the Akt/GSK-3beta/CRMP-2 pathway is involved in axon degeneration induced by MPP+
Clear differences in CRMP2 protein abundance and degradation product/short isoform were observed between ischemic core and penumbra (show TSPAN33 Antibodies) and also compared to the contralateral healthy tissues after PACAP38 (show ADCYAP1 Antibodies) or saline treatment.
This gene encodes a member of the collapsin response mediator protein family. Collapsin response mediator proteins form homo- and hetero-tetramers and facilitate neuron guidance, growth and polarity. The encoded protein promotes microtubule assembly and is required for Sema3A-mediated growth cone collapse, and also plays a role in synaptic signaling through interactions with calcium channels. This gene has been implicated in multiple neurological disorders, and hyperphosphorylation of the encoded protein may play a key role in the development of Alzheimer's disease. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene.
collapsin response mediator protein hCRMP-2
, dihydropyrimidinase-related protein 2
, unc-33-like phosphoprotein 2
, collapsin response mediator protein 2
, neural-specific protein NSP60
, turned on after division 64
, dihydropyrimidinase-like 2
, turned on after division 64 kDa protein
, turned on after division, 64 kDa protein
, collapsin response mediator protein CRMP-62
, collapsin response mediator protein-2A
, dihydropyrimidinase-related protein 2-like